Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.

CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Abstract Text:

    ellen m whyteEllen M Whyte,marjorie romkesMarjorie Romkes,benoit h mulsantBenoit H Mulsant,margaret a kirshneMargaret A Kirshne,amy e begleyAmy E Begley,charles f reynoldsCharles F Reynolds,bruce g pollockBruce G Pollock,

    INTRODUCTION: The elderly are at increased risk for medication-related adverse events. Recent reports indicate that venlafaxine may put the elderly at increased risk of cardio- and cerebrovascular adverse events. We investigated the relationship between the CYP2D6 polymorphism and steady-state plasma concentration of venlafaxine (VEN) and its primary metabolite o-desmethylvenlafaxine (ODV) in elderly participants receiving venlafaxine-XR for major depression in order to explore the contribution of pharmacogenetics to medication tolerability. METHODS: Forty-six elderly participants received venlafaxine-XR for the treatment of major depression. CYP2D6 genotype and steady-state plasma levels of VEN and ODV were determined. RESULTS: Sixty-five percent of participants were homozygous of the wild type (WT) allele, whereas 35% carried one or more variant alleles associated with intermediate and poor 2D6 metabolizer status. VEN concentration per unit dose was significantly higher and ODV concentration per unit dose was significantly lower in participants who carried one or more variant alleles compared to participants who were homozygous for the WT allele. The VEN and ODV concentrations per unit dose were also correlated with creatinine clearance. CYP2D6 genotype was not associated with medication associated side-effects. CONCLUSIONS: Plasma dose-corrected concentrations of VEN and ODV correlated with genetically determined CYP2D6 enzymatic activity in depressed elders treated with venlafaxine-XR. This relationship was not masked by the effects of age-related illness or polypharmacy. Future clinical application of pharmacogenetics to examine 2D6-dependent medications may help reduce the incidence of medication adverse events particularly in those elders at higher risk for medication adverse events due to impaired renal or cardiac function.

    CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Publishing Authors By Initials

    em whyteEM Whyte,m romkesM Romkes,bh mulsantBH Mulsant,ma kirshneMA Kirshne,ae begleyAE Begley,cf reynoldsCF Reynolds,bg pollockBG Pollock,

    For similar male research abstracts see: male research

    PUBMED ID PMID:

    MEDLINE DATE:

    CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: International journal of geriatric psychiatry

    VOLUME: 21

    Page Numbers: 542-9

    Journal Abbreviation:

    ISSN: 0885-6230

    DAY: 3

    MONTH: Jun

    YEAR: 2006

    CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8710629

    CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Keywords Mesh Terms:

    KEYWORDS: Male

    MESH TERMS: genetics

    Chemical & Substance for Abstract: CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Information

    Substance Name: Cytochrome P-450 CYP2D6

    Registry Number: EC 1.14.14.1

    Grant and Affiliation Information for CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.

    AFFILIATION: Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIMH

    GRANT: MH65416

    ACRONYM: MH

    MEDLINETA: Int J Geriatr Psychiatry

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News